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Abstract: Gynaecological cancers are the fourth most common form of cancer and the fifth most common
cause of cancer mortality for women in Australia. Definitive treatment is available in tertiary hospitals
in major capital cities. This study aimed to understand how care is received by women in order to improve
both their experience and outcomes. We interviewed 25 women treated for ovarian, cervical and uterine
cancers in public or private hospitals in four states, including urban, rural and Indigenous women.
Referral pathways were efficient and effective; the women were diagnosed and referred for definitive
management through well-established systems. They appreciated the quality of treatment and the care they
received during the inpatient and acute phases of their care. Three main problems were identified – serious
post-operative morbidity that caused additional pain and suffering, lack of coordination between the
surgical team and general practitioners, and poor pain management. The lack of continuity between
the acute and primary care settings and inadequate management of pain are acknowledged problems in
health care. The extent of post-operative morbidity was not anticipated. Establishing links between the
surgical team and primary care in the immediate post-operative period is crucial for the improvement
of care for women with gynaecological cancer in Australia. © 2012 Reproductive Health Matters
Keywords: ovarian cancer, uterine cancer, cervical cancer, continuity of care, post-operative morbidity,
women’s health services, rural health, Australia
Women’s reproductive health includes gynaecological
cancers, although this link is made rarely. Repro-
ductive Health Matters drew attention to this deficit
in 2008 when it focused primarily on cervical and
breast cancer.1 This article covers uterine, ovarian
and cervical cancer, its diagnosis, management
and outcomes in a well-resourced health system.
About 27% of Australia’s population of 23 mil-
lion live in regional (large rural towns), rural or
remote areas in a land mass nearly the size of
Europe.2 Delivery of health services to these areas
is a continual challenge.
Efforts to improve the quality of cancer care
in Australia have been supported by significant
government attention since 2005. The National
Service Improvement Framework for Cancer is
driving improvements in health service delivery.3–9
Cancer is one of the five national priority health
areas and the Framework provides policy guide-
lines for health planners and professionals. It is
structured to reflect the patient journey from reduc-
ing risk, early detection, management of the acute
phase, long-term care and terminal care.
Gynaecological cancers are the fourth most
common form of cancer for women in Australia and
the fifth most common cause of cancer mortality.
In 2007 the age standardised incidence of uterine
cancer was 16.5 per 100,000 women, 10.8 for
ovarian cancer and 6.8 for cervical cancer.10 The
risk of uterine cancer by age 85 in Australia was
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1 in 50, ovarian cancer 1 in 78, and cervical cancer
1 in 158.11 Gynaecological cancers accounted for
8.5% of all female cancer deaths and ovarian
cancer was in the top ten most common causes
of cancer deaths in women, with an incidence of
7 deaths per 100,000.
The incidence of cervical cancer was signifi-
cantly higher for Indigenous than non-Indigenous
Australians.10 There is a comparatively high rate
of gynaecological cancers among Indigenous
women, particularly those living in remote and
rural regions. Lack of access to primary care because
of poverty, shortage of services, distance and
cultural barriers makes it difficult for Indigenous
women to receive screening, diagnosis and treat-
ment for gynaecological cancers.12
Geography did not influence survival from
uterine cancer between 2003 and 2007,13 but
five-year survival for ovarian cancer decreased
with increasing remoteness from 45% in major
cities to 36% in outer regional areas. Five-year
survival for cervical cancer was 74% in major cities
but only 58% in remote and very remote areas.13
If cancer of the uterus is detected early, 70–95%
of women survive at least five years, and most
are cured.14 If ovarian cancer is treated when it
is still confined to the ovaries, 93% of women will
be alive in five years. If the cancer has spread
to surrounding tissue or organs in the pelvis, this
drops to 39%. Cervical cancer is easier to diag-
nose than uterine or ovarian cancer, and treat-
ment is effective.10 To have a chance of survival
women require timely diagnosis and extensive
surgical excision of the cancer, which may involve
other structures such as the bladder and bowel.
The intensity of treatment contributes to the
stress of the experience and has been shown to
lead to post-traumatic stress disorder.15 A UK study
found that six months after treatment for gynae-
cological cancer women still had an average of
four major concerns relating to illness, treatment
and outcomes.16
Australia has a well-developed health care
system and universal health insurance that ensures
all citizens can access essential medical care with-
out cost being a major barrier. Gynaecological sur-
gical care is provided in tertiary hospitals, all of
which are located in major cities. In 2011 the
number of skilled surgeons was small – 45 spe-
cialist gynaecological oncologists (12 women) and
seven gynaecologists training in the sub-specialty
(3 women) (Royal Australasian College of Obstetri-
cians and Gynaecologists, Personal communica-
tion, September 2012). Surgeons interviewed in
2008 reported being overworked and tired.17
General practitioners comprise the bulk of the
medical workforce distributed throughout Australia.
Women living in regional and rural areas are depen-
dent on general practitioners for referral for curative
surgical care and for post-operative management.
There are 157 regional hospitals that admin-
ister chemotherapy, out of 761 public hospitals
and 543 private hospitals. Rural people are more
likely to die of cancer within five years of diag-
nosis than urban people and restricted access to
care contributes to this.18
This qualitative study of the experiences of
women receiving gynaecological cancer treatment
adds the voice of women to the national discus-
sion about cancer care, identifying strengths and
gaps in services.
Method
This was an empirical case study with data from
in-depth, semi-structured interviews with 25 women
who had been treated for any type of gynaecological
cancer. A purposive sample was recruited from five
cancer treatment centres in Victoria, New South
Wales, South Australia and the Northern Territory
during 2008, and one consumer representative.
These centres were selected for variation in geo-
graphic location (metropolitan-regional-rural) and
included both public and private hospitals. This
was the maximum number and variation of women
we could recruit within the resources of the study.
Inclusion criteria were having received treatment
for gynaecological cancer. Exclusion criteria were
being too ill to take part or unable to provide
informed consent. The interviews with the Indige-
nous women are also reported elsewhere.12
Interviewing women about the quality of treat-
ment was a delicate exercise. An opt-in model was
used to recruit participants from treatment clinics.
Staff handed out an information flyer inviting
women to make direct contact with the research
team, who were independent of the treatment
team. Those who contacted us were invited to
take part in an interview. The decision to partici-
pate or not was not known to the treatment
teams. Ethical approval for the study was granted
by the ethics committees of the five treatment
centres, and two universities.
Semi-structured interviews were conducted
face-to-face (n=19) or by telephone (n=6) taking
60–90 minutes.19 Women were asked to begin
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with the story of how they found out about their
cancer. They were asked about their experiences of
the care provided by medical, nursing and allied
health professionals, and outcomes of treatment.
All interviews were audio recorded with permission
and were transcribed by a professional service.
Thematic analysis of transcripts was carried out
using NVivo8 qualitative analysis software.20 This
software is based on Grounded Theory, in which
data themes are generated from the data rather
than a priori.21 Approximately 10% of the data were
analysed independently by two members of the
team and checked for variation in interpretation.
Findings concentrate on diagnosis, access and
outcomes of care. Codes in brackets with quotes
specify each woman by a number and R (for rural),
U (for urban) and I (for Indigenous). Patient stories
are taken from interview transcripts. They have
been shortened and modified to ensure intelli-
gibility and remove identifying information but
remain faithful to the original text.
Findings
Seventy-four women were approached for the
study. Of the 68 who were eligible, 30 agreed to
take part, of whom 25 were interviewed. The
sample included 12 urban, 4 regional and 9 rural
women. Three of the rural women were Indige-
nous. Rural woman and Indigenous women were
specifically sought for the study, rural women by
recruitment from rural clinics, and Indigenous
women who were contacted by an Indigenous
researcher. Twenty of the women were treated in
a public hospital (5 urban Victoria, 6 rural New
South Wales, 2 urban South Australia, 4 regional
Northern Territory, 3 Aboriginal rural South
Australia), and five in a private hospital (4 urban
South Australia, 1 urban New South Wales).
Ten of the women had uterine cancer, seven
ovarian cancer and eight cervical cancer; all but
three were primary cancers. Six were diagnosed
more than five years prior to the study, 16 one
to five years previously, and three less than a year
before. Their average age at interview was 58,
with one woman aged less than 30 and three
aged 71–85. Sixteen of the women were married,
five divorced, three widowed, one single, and all
but three had children. Eight were living alone.
Pathways to care
The primary care system worked well for most
women. The diagnostic journey started either with
a routine Pap smear or symptoms that prompted
them to consult their general practitioner. Gynae-
cological cancer can be difficult to diagnose because
there may be no symptoms, or symptoms may
not be specific to cancer. Symptoms reported by
the women included pain in the bladder, lower
abdomen, bowel and chest, painful sexual inter-
course, bleeding from the vagina, swelling of the
abdomen, lumps in the groin and a generalised
feeling of being unwell associated with leg pain.
Most women went from diagnosis to treatment
in a well-oiled system that took care of them each
step of the way. Urban women were more likely
than rural women to be referred directly to a gynae-
cological oncologist (5 urban, 1 rural). Regional and
rural women had more complex pathways to diag-
nosis, intervention, and post-intervention care than
urban women, largely as a result of variations in
service availability in rural areas.
Most of the women sought immediate help
when they experienced symptoms.
The time between presentation with symptoms
and diagnosis was short, with nine women being
diagnosed within two days and another five within
two weeks of seeing their doctor (Table 1). Four
women had no symptoms and were diagnosed at
routine Pap smear (two others had had recent
normal smears). Three women were misdiag-
nosed and treatment was delayed, with serious
consequences. It took one woman three years to
obtain a diagnosis of cancer despite repeat visits
to a family planning clinic. By that time the cervical
adenocarcinoma had spread and required radical
surgery. At the time of interview ovarian cancer
had been identified and she was due for further
surgery. Another woman had equivocal pathology
findings for cervical cancer that led her to agree
to a hysterectomy after eight months. In an attempt
to preserve her hormone function, in case radio-
therapy was required, her ovaries were moved
to the front of her abdomen. At operation, it was
found that she did not have cancer.
For most women, the general practitioner made
a provisional diagnosis of gynaecological cancer
and referred her to a gynaecologist and/or a gynae-
cological oncologist for investigation, confirmation
of diagnosis and treatment. Twenty-four women
had a radical hysterectomy regardless of type
of cancer and one had a radical trachelectomy
(excision of the cervix). An additional surgeon was
involved for five of the women. Follow-up treat-
ment included chemotherapy, radiotherapy includ-
ing brachytherapy (radiation pellets delivered to
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the site of the tumour), or both. Most women were
followed up by the treating surgeon, and 19 had
a general practitioner for general health care, of
whom 14 were involved in follow-up cancer care
after treatment. The six who did not have post-
operative care with a general practitioner were
managed by hospital teams, a gynaecological
oncologist or gynaecologist. Treatment teams were
similar for the three types of cancer.
One woman was immunosuppressed as the
recipient of an organ transplant, another deve-
loped ovarian cancer secondary to abdominal
cancer with involvement of the bowel, a third had
bowel cancer identified at surgery, and another
had uterine cancer associated with cancer of the
stomach. One woman with ovarian cancer as a pri-
mary diagnosis also had primary Hodgkins lym-
phoma treated with chemotherapy and radiotherapy.
Seven women had a hysterectomy without
further treatment. The seven women with ovarian
cancer all had chemotherapy, as did three with
uterine cancer and one with cervical cancer. Two
of the women with uterine cancer and two with
cervical cancer had radiotherapy. Two women with
uterine cancer had brachytherapy. The woman
with ovarian cancer and Hodgkins lymphoma had
both chemotherapy and radiotherapy.
All the women continued to be monitored
monthly, three monthly or annually by their gen-
eral practitioner, the gynaecological oncologist
who performed the surgery, or a gynaecologist.
Access to treatment and cost
Access to health services was swift and appropriate
for all women once a correct diagnosis had been
made, although more difficult for rural women.
Eighteen women had surgery within two weeks of
diagnosis. One woman who was asymptomatic
and diagnosed by Pap smear had her CIN3 result
communicated to her only after a nine-month
delay. For the remaining women, additional time
was needed to organise care among the treatment
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team, or pre-operative chemotherapy or radiation
therapy. Several women delayed treatment while
they considered their options, and one took a
long-planned holiday first. Almost all women
commented favourably on the timeliness of care
although a few found it difficult to assess the bene-
fits of suggested therapies or surgery in the short
time they were given.
The women who received all their care in the
public system had few medical costs, while those
who had private health insurance were left with
out-of-pocket expenses linked to their level of
health insurance. Costs ranged from a few hun-
dred Australian dollars to more than A$5000
out-of-pocket expenses. Additional costs were
incurred by those who had to travel, and in lost
time from work for themselves and their partners.
Quality of care
The women defined quality care as care they
could be confident in. This required a mixture
of a positive attitude among staff, giving women
hope of a good outcome, and confidence that
the team members were efficient and knew what
they were doing. The women appreciated the
sense of safety that came with trust in their sur-
geon. They responded well to staff who kept their
hope alive. Overall, the gynaecological workforce
were seen to offer high quality patient-centred
care, personal support, appropriate information
and smooth transitions from one aspect of care
to another, so that they felt their team were skill-
ful and communicated both with each other and
with them and their families.
The women developed a more intense thera-
peutic relationship with their doctor than with
nurses or allied health professionals. Women
spoke of their doctor and knew his or her name,
while nurses were spoken of in very general terms
and their names were not known.
Outcomes of treatment
Gynaecological cancer focuses on a woman’s sexual
functioning and body parts that define her as
female. A radical hysterectomy removes these
organs and involves parts of the body that are
not usually spoken about, making normalisation
of the experience through small talk unavailable.
This can challenge a woman's sense of femininity
and of being a whole person. A small number of
women described feeling “dirty”, no longer a
woman, sexually unattractive and doubtful about
gender identity. Some women found the surgery
very confronting, along with the sense of power-
lessness, dependency, and being out of control of
their lives, as well as the physical pain and dif-
ficulty. Even women who did not have adverse
outcomes found the experience of diagnosis and
treatment traumatic.
“It’s a very scary experience because you go from
finding something and then it’s all blood tests
and scans and ultrasound and then you go through
major surgery and then the chemo and you’re just
bewildered.” (U5)
“You go in feeling extremely well and not really
knowing there was anything wrong… and from
then on your life becomes a bit of a misery because
this doesn’t work and the bowels won’t work prop-
erly and all that stuff… When we did the opera-
tion the surgeon was really excited. ‘I’ve got it all’,
he said, ‘and that’s it.’ But, of course it isn’t. That’s
not the full story and nobody knows what the full
story is.” (U3)
The experience of cancer and its treatment could
be “traumatic” and “horrific” and left some
women feeling angry. The differences in their
experience derived from variations in response
to treatment, particularly for those with post-
operative complications.
Life after treatment and adverse events
Although the journey forward could be compli-
cated, painful and difficult and the outcome uncer-
tain, the moment of recovering from the surgery
and being sent home, free of observable cancer,
was a moment to be savoured. All but two of the
women were in remission at the time of interview.
One woman who was not in remission had had
ovarian cancer that was excised, and a small tumour
that was being monitored, the other had just been
diagnosed with ovarian cancer at the time of inter-
view and was awaiting further surgery. They were
very conscious of the gift of extra life they had been
given, and many dismissed the distress of the inter-
ventions as unimportant compared with that.
Eleven women had adverse outcomes after dis-
charge from hospital that required further medical
management; the others progressed as expected
(Table 2). Two women had post-operative infections
including a rural woman who became critically ill
with septicaemia, two had debilitating depression,
one had persistent inter-menstrual bleeding, one
woman was dealing with a hernia four years later
that was a result of the surgery, and another had
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a rectal prolapse and hernia. One woman with
ovarian cancer experienced serious bowel compli-
cations. She required re-section and re-anastomosis
of the bowel at the time of gynaecological surgery.
She was told that the blood vessels were not
joined properly, leading to initial paralysis of the
bowel, severe constipation and pain. She was
advised that this was a permanent condition and
required lifelong medication (R1’s story).
The woman who had a hysterectomy but
turned out not to have cancer suffered persistent
abdominal pain, as her ovaries (which had been
moved) became surrounded by adhesions and a
nerve was also involved. She was hospitalised as
a result and was struggling with the impact on
her marriage and her joy of life, because the
only “solution” the surgeon could offer was to
remove the ovaries, which she rejected. She is
now extremely wary of mainstream medicine and
appeared depressed, angry and sad.
An Aboriginal woman with cervical cancer had
morphine apnoea during surgery and stopped
breathing, with possible cardiac arrest, and had
to spend time in intensive care recovering. She
was admitted to hospital when she returned to
her local community because of chest pain and
concern about bowel obstruction (I1’s story).
R1’s story
R1 was age 61, married with 3 adult sons, living in
a rural area 300 km from capital city. Left school at
15. Operated for ovarian cancer at a public hospital.
I must have had problems for probably six years
before it was diagnosed and they just said it was
the change of life. I had heavy bleeding. It was
never like a severe pain, more like a small tooth-
ache. The pain was starting to annoy me and
I had an ultrasound in June in 1999. The doctor
rang me next day and said he felt that there was
a tumour on the right ovary. From the minute that
chap held the picture up to the window, he said to
me ‘You’re in trouble’. I still wasn’t concerned
because I wasn’t sick. He said to me ‘You’re going
to have to go to (capital city)’. Because he could
see that it was the ovary, tied up with the bowel
as well. We were at (tertiary hospital 5 hours drive
away) 2 weeks later and saw Dr X, I think she is
God. Next day I had the operation, a total hyster-
ectomy and 11 inches of bowel removed.
I was only there a week. Then they took the staples
out. Dr X wasn’t there and I saw someone else and
we came home by car. This doctor told me that
because I was leaving the hospital it was no longer
anything to do with them. ‘When you get home you
go and see your GP. If you have any problems you
get in touch with your GP.’ When I got home I was
extremely ill. My innards didn’t work. Nothing
worked. So when I rang my GP he promptly informed
me that he had no idea what I’d had done. There
was no paperwork. There was no follow up and he
wouldn’t make a house call and I was too sick to
get out of bed. So I was in real strife. A week later
I went over to the cancer clinic in (town across the
state border) and that was when I got all the help.
So for a week I just laid here and I was in real strife.
I was in extreme pain, extreme. I had been so well in
hospital and I felt like you were just dumped once
you got home. Just no help at all.
I started the chemotherapy straight away. All the
help and all the care and everything I got was
just wonderful. Which it was in (capital city), too,
it was just that awful week where there was
no help, nothing. The chemo made me very sick
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and there were days when I just lay on the
bathroom floor with my head in the toilet, so
it was pretty ordinary.
Palliative care came about a month later. I opened
the door and the lady said ‘I’m from palliative
care’ and I said ‘But I’m not dying!’ I found the
palliative care, the nursing side of it, they were
wonderful, and we really only ever had to call
on them once at night when I was in extreme pain
from the chemo. That night they were here in next
to no time and followed up with phone calls.
The pain was extreme, like contractions. See, I’m
sort of cut right down here and because I was
having all the pain there it was just terrible. They
just tell you that’s forever. The medication that
I’m on is good but I can’t ever stop the medication
because once you stop you’re in real trouble again.
They feel it was because the blood vessels weren’t
joined up properly during the surgery. Quite a few
of the people I’ve gone through with have passed
away, so that makes me feel I was very lucky.
Discharged without ongoing care
A major negative finding was that some women
were discharged from hospital without adequate
ongoing care or information. Four women described
the shock of getting home and not knowing what
to do as the worst part of their experience. They
felt too sick to manage and either could not get
the help they needed, or struggled to do so. The
shock of being left on their own after the inten-
sive management in hospital was extreme. One
woman’s husband had to leave for work the morn-
ing after she got home, for example, and in spite
of very bad pain she had to make food, take her
insulin and look after herself, and felt completely
helpless. “After he’d gone to work I just laid there
and cried and I thought ‘What do I do?’” (U5)
Pain management
Effective and ineffective pain management occurred
for both urban and rural women and in public
and private hospitals. The women had different
levels of need for pain relief, and good pain man-
agement mattered to them. When it went wrong,
it left lasting effects.
Several women described not having pain or
not being troubled by it, despite major surgery.
Eighteen of the 25 women described their pain
as being well managed. Even in a well-resourced
health system such as Australia’s, however, pain
was not managed well for seven of the women,
who experienced unnecessary and distressing pain
associated with treatment and/or post-operatively.
The doctors were described as being very atten-
tive to pain management, but some women strug-
gled to get pain relief from nurses. One woman was
very distressed when the staff would not believe
her or respond when she said she was in pain. It
took 20 minutes before a nurse realised the mor-
phine drip tubing was kinked and no analgesia
was getting through. Another woman endured an
under-trained nurse trying to manage her epidural,
and a doctor only intervened after 45 minutes, by
which time the pain was extreme (U2’s story).
Several women experienced pain during che-
motherapy, which was well managed either by
the chemotherapy unit, the general practitioner
or the palliative care nurses.
Several women had significant complications
and pain was a major issue for them. One woman
was eventually hospitalised due to a bowel obstruc-
tion some time after her surgery for cervical cancer,
after she had struggled to get the pain manage-
ment she needed as an outpatient.
I1’s story
I1, aged 64, Aboriginal, lives 600 km from city,
lesbian partner, 1 son. Treatment for uterine cancer
in private hospital.
I have a marvellous GP here who picked it up
straightaway. I went in and told her the symptoms,
that a couple of times in the supermarket I felt like
a knife had gone through my left side. Then there
were some telltale signs with pain and bleeding.
A week later I was in theatre. I had CIN1, cancer
of the uterus.
The nursing was absolutely wonderful. The sur-
geon, he won’t win any prizes for his social skills,
but he’s a marvellous surgeon and only one per-
cent of his patients ever get lymphodema. Every-
thing was taken away, I have nothing in the
nether regions now. My surgeon was first class,
the nursing care was first class but the anaesthe-
tist I’m not too sure about. I had a reaction to
morphine because they probably gave me too
much and I stopped breathing and I was in inten-
sive care and that was pretty awful. I recovered
from that but getting over the cancer was pretty
hard. It was hard physically.
God, that first night after the op I’d come back
from ICU I had the most marvellous nurse on
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and what we did – we worked it out together.
I couldn’t even take paracetamol at that point so
she would come every hour and move me around
and put a wet cloth on me and straighten my
sheet so that I could sort of cope with the pain.
That’s really good care. A country lass, you know?
I was allowed to go onto paracetamol pretty
quickly because that’s all I could tolerate. That’s
pretty hard when you’ve had major surgery.
I got a bit of a staph infection in the wound and
they had to come in every day to dress it. It was
a very hard time and it was an awful experience
in terms of physical pain. It’s a real process. It
takes such a long time to recover from cancer of
the uterus. But I’ve come good and I’m as healthy
as a trout.
Rural women: additional challenges
Women who live in regional, rural and remote
areas are faced with the additional challenge of
leaving their home and familiar environment to
access surgical care, while managing transport
and accommodation in a crowded, fast-moving
and alienating city environment. Travel distances
included up to 200 km by road to an airport
and up to 3,000 kilometres by air to a city. Con-
sultations prior to surgery and chemotherapy
and radiotherapy after surgery were available
in regional centres, but those may also be hun-
dreds of kilometres away from home and require
repeat visits.
A woman from a remote area declined post-
operative chemotherapy in the distant city where
she had had surgery because she just wanted to
go home. She had no effective analgesia, had
extensive nerve damage to her bladder from the
hysterectomy and had lost the ability to urinate.
She was discharged with a post-operative infection
that required surgical drainage and an in-dwelling
catheter, and had to be taught to catheterise herself
when she got home. She had no support person for
the 3,000 km plane trip, but said she would have
“crawled over the tarmac” to catch the plane rather
than stay in the city.
Another rural woman had a traumatic post-
operative course. She stayed with her son in the
city for a couple of days post-operatively. Her
stitches broke and she had to wait for 12 hours
on a trolley at a nearby hospital to be re-admitted
to theatre to repair the wound. She contracted
golden staph, developed septicaemia, and spent
six weeks in a city hospital, including a week in
rehabilitation to learn to walk again. She then
caught the train home on her own with her wound
still open. There was no care provided for her when
she arrived home and no review appointment.
She had rung the local hospital for help and was
told they did not provide care for people on the
other side of the State border. No-one suggested
she contact her GP so she did not do so. Her
memory has been affected, and she is now fearful
of surgery and putting off a hernia repair.
U2’s story
U2 was married with two children, aged 21 and
24, living at home. Aged 48 when cancer diag-
nosed, 49 at time of interview. Surgery for ovarian
cancer in an urban private hospital, in remission
at interview.
It started they think, from the lining of my
tummy. I had all the lining of my tummy taken
off, which meant I had to have my spleen and
my pancreas basically scraped. It went down into
my ovaries. So they’re putting it down as ovarian
cancer because they’re not really sure exactly
where it started. Then it went onto the outside
of my bowel. So I had about two-thirds of my large
intestine removed.
I had massive amounts of pain – for years, every
four weeks I’ve had a sharp pain and the doctor
and gynos and naturopaths would put it down
to irritable bowel. I went to (doctor) and we had
X-rays done and I was absolutely bent over in pain
and he referred me to a gynaecologist. At 9 o’clock
that night I got a phone call from (gynaecologist)
and he said to me ‘you’ve got cancer and it doesn’t
look good. We’ve got to get you into hospital
straight away’.
So I had the operation and woke up cut to shreds.
I had a drip on this side, a hole there, cut from
here right down to the vagina bone and then an
illiostomy bag over here and drips here.
After the operation, in intensive care (ICU), one of
the nurses was not trained on replenishing the
epidural and like you’re laying there 5 hours after
you’ve had this operation and you’ve had your
stomach completely cut open and she’s standing
there trying to get it to go. Ten minutes later, no
pain relief. A male nurse came in and I grabbed
his hand and I said ‘Don’t you leave me here.
Don’t you go. Stay with me’ because I didn’t trust
her. In the end they got a doctor to come in,
he turned me over and you just bear it. But by
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the time it started working the pain had got up to
the highest level that you could imagine. It was
very traumatic.
I was in hospital for ten days and needed quite
a few blood transfusions. They didn’t let me have
any rest at all. I was out of hospital and then,
wham, I had the full bit (chemotherapy). I couldn’t
praise the hospital more highly. The nurses were
great. Just don’t let ICU happen again.
Discussion
This study found that the referral pathways to treat
gynaecological cancer were efficient and effective;
the women were diagnosed and referred for defini-
tive management through well-established sys-
tems. They appreciated the quality of treatment,
the efficiency and the care they received during
the inpatient and acute phases of their care.
However, we identified three main problems –
the experience of post-operative morbidity that
caused additional pain and suffering, the lack of
coordination between the surgical team and gen-
eral practitioners, and poor pain management.
These did not appear linked to the type of cancer,
but rather to the radical surgery experienced by
almost all the women. Moreover, the concentration
of surgery in tertiary hospitals meant women had
to travel to receive care, which in some instances
resulted in a disconnect between the surgical
team and the local medical system.
An unanticipated finding was the high propor-
tion of women who experienced post-operative
complications, beyond those normally associated
with recovery from surgery. Some of these were
life-threatening and many were poorly managed,
or there was such a delay in management that
they caused considerable trauma. Discrepancies
in pain management were also identified, and
must be addressed.
Cancer treatment can be traumatic, with lasting
adverse effects,15,16 despite excellent clinical care
and the outcome of lengthened life.22 The worst
period identified by the women in this study was
the immediate post-operative weeks, when they
were at their weakest and most vulnerable. Women
with no one at home to nurse them and rural
women were particularly at risk. Some women felt
abandoned and unable to obtain medical care
following discharge from hospital. Only when they
made contact with their general practitioner, che-
motherapy or radiotherapy team, and attended
their post-operative check-up with the gynaecologi-
cal oncologist, did care appear to be re-established.
The lack of effective linkages between the acute
and primary sectors of the health system has been
identified as a significant problem for many
groups of patients and conditions. Communication
between specialists and hospitals, on the one
hand, and general practitioners on the other has
been the subject of hospital-based reform since
the mid-1990s.22,23 The fact that it also emerged
in this study was not unexpected, and was par-
ticularly problematic when the women lived far
from the hospitals where they received treatment.
Nevertheless the strength and volume of commen-
tary on this problem, mentioned by almost all the
women, was striking, and underlines its impor-
tance. Clearly, far more careful attention is needed
in discharge planning and communication to
arrange the handover of women from the surgical
team to their gynaecologist or general practitioner,
or both.
Although we interviewed a small number of
women, and make no claim of generalisability,
distinct patterns emerged from the interviews
which make us confident that these experiences
were a valid portrayal of what can go right and
wrong in the clinical management of gynaecological
cancer. This study focused on women who were
undergoing follow-up treatment. We did not inter-
view women who were ill or in hospital, who may
have had different perspectives. There is also a
survivor bias. Nevertheless, we learned about a
range of experiences of both rural and urban
women in a wide variety of treatment centres in
four states of Australia, which gives our findings
value and validity.
Recommendations
Discharge of all women to a general practitioner
who is involved as part of the treatment team is
critical. Every woman leaving hospital must be
given a 24-hour contact number and an appoint-
ment with her referring doctor within 24 hours
of discharge. Attention to effective pain manage-
ment for all stages of diagnosis and treatment
would also improve women’s experience of care.
Establishing reliable, consistent links between
the surgical team and primary care in the immedi-
ate post-operative period is the most important
challenge to the improvement of health system
effectiveness for women with gynaecological
cancer in Australia.
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Résumé
En Australie, les cancers gynécologiques sont la
quatrième forme de cancer en termes de fréquence
et la cinquième cause de mortalité par cancer chez
les femmes. Un traitement définitif est disponible
dans les hôpitaux tertiaires des principales capitales
d’États et territoires. Cette étude souhaitait
comprendre comment les soins sont reçus par
les femmes pour améliorer leurs expériences
et les résultats. Nous avons interrogé 25 femmes
urbaines, rurales et aborigènes traitées pour un
cancer des ovaires, du col de l’utérus et de
l’utérus dans des hôpitaux publics ou privés
de quatre États. Les filières d’aiguillage des
patientes étaient efficaces ; les femmes étaient
diagnostiquées et orientées pour une prise en
charge définitive par des systèmes bien établis.
Elles appréciaient la qualité du traitement et
des soins reçus pendant les hospitalisations et
les phases aigües des soins. Trois principaux
problèmes ont été identifiés : la morbidité
post-opératoire qui causait des douleurs et des
souffrances supplémentaires, le manque de
coordination entre l’équipe chirurgicale et les
médecins généralistes, et la médiocre gestion
de la douleur. Le manque de continuité entre
les services de soins aigus et primaires, et la
prise en charge insuffisante de la douleur sont
des problèmes connus des soins de santé.
L ’ampleur de la morbidité post-opératoire
n’était pas prévue. Pour améliorer les soins des
femmes présentant un cancer gynécologique
en Australie, il est essentiel d’établir des liens
entre l’équipe chirurgicale et les soins primaires
immédiatement après l’intervention.
Resumen
El cáncer ginecológico es el cuarto tipo más
común de cáncer y la quinta causa más común
de mortalidad por cáncer de las mujeres en
Australia. En las principales capitales, se ofrece
tratamiento definitivo en hospitales terciarios. El
objetivo de este estudio fue entender cómo los
servicios son recibidos por las mujeres con el fin de
mejorar tanto su experiencia como los resultados.
Entrevistamos a 25 mujeres, urbanas, rurales e
indígenas, atendidas por cáncer ovárico, cervical y
uterino, en hospitales públicos o privados de cuatro
estados. Las vías de referencia fueron eficientes y
eficaces; las mujeres fueron diagnosticadas y
remitidas para manejo definitivo por sistemas
bien establecidos. Ellas agradecieron la calidad
del tratamiento y los cuidados que recibieron
durante las fases de internación y atención
aguda. Se identificaron tres problemas principales:
morbilidad postoperatoria adversa, que causó
dolor y sufrimiento adicionales, falta de coordinación
entre el equipo quirúrgico y los médicos generales
y deficiente manejo del dolor. La falta de
continuidad entre los ámbitos de atención
aguda y primaria y el manejo inadecuado
del dolor son problemas reconocidos en los
servicios de salud. No se previó el grado de
morbilidad postoperatoria. Para mejorar los
servicios que reciben las mujeres con cáncer
ginecológico en Australia es de importancia
fundamental establecer vínculos entre el equipo
quirúrgico y la atención primaria en el período
postoperatorio inmediato.
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